According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below:
Solar Senior Capital Ltd (SUNS, Financial): CEO, President Chn of the Brd Michael S Gross Bought 42,824 Shares
CEO, President Chn of the Brd of Solar Senior Capital Ltd (SUNS) Michael S Gross bought 42,824 shares during the past week at an average price of $17.4. Solar Senior Capital Ltd. operates as a business development company under the Investment Company Act of 1940. Solar Senior Capital Ltd has a market cap of $165.5 million; its shares were traded at around $17.4 with a P/E ratio of 20.7 and P/S ratio of 21. The dividend yield of Solar Senior Capital Ltd stocks is 7.2%.
SUNS recently reported earnings of $3.6 million, or $0.38 per share, and net investment income of $3.4 million, or $0.36 per share, for the quarter ended June 30, 2012. Net asset value (NAV) per share increased to $18.54, from $18.15 at December 31, 2011.
CFO, Secretary and Treasurer Richard Peteka bought 1,487 shares of SUNS stock on 05/31/2012 at the average price of 16.45. Richard Peteka owns at least 6,250 shares after this. The price of the stock has increased by 5.78% since. Other insiders have also decreased their positions in the company.
Pacific Biosciences of California (PACB, Financial): Chairman, CEO & President Michael Hunkapiller Bought 400,000 Shares
Chairman, CEO & President of Pacific Biosciences of California (PACB) Michael Hunkapiller bought 400,000 shares on 08/07/2012 at an average price of $1.81. Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. Pacific Biosciences Of California has a market cap of $94.4 million; its shares were traded at around $1.81 with and P/S ratio of 2.8.
PACB recently reported its second quarter 2012 financial results. Gross profit for the second quarter of 2012 totaled $0.3 million, resulting in a gross margin of 4%, compared to a $0.2 million gross loss for the first quarter of 2012 and a negative margin of 2%. Gross profit for the second quarter of 2011 was $7.9 million representing a gross margin of 74%.
Jean-Marie Eveillard bought 150,000 shares in the quarter that ended on 03/31/2012, which is 0.002% of the $25.09 billion portfolio of First Eagle Investment Management, LLC. Lee Ainslie owns 3,543,333 shares as of 03/31/2012, which accounts for 0.17% of the $6.95 billion portfolio of Maverick Capital. John Griffin owns 870,000 shares as of 03/31/2012, which accounts for 0.049% of the $6.04 billion portfolio of Blue Ridge Capital.
General Motors Company (GM, Financial): Chairman & CEO Daniel F Akerson Bought 25,000 Shares
Chairman & CEO of General Motors Company (GM) Daniel F Akerson bought 25,000 shares on 08/08/2012 at an average price of $20.54. General Motors Company is engaged in the designing, manufacturing and retailing of vehicles globally including passenger cars, crossover vehicles, and light trucks, sport utility vehicles, vans and other vehicles. General Motors Company has a market cap of $31.39 billion; its shares were traded at around $20.54 with a P/E ratio of 6.2 and P/S ratio of 0.2.
GM recently announced second quarter net income attributable to common stockholders of $1.5 billion, or $0.90 per fully diluted share. In the second quarter a year ago, GM’s net income attributable to common stockholders was $2.5 billion, or $1.54 per fully diluted share.
Mohnish Pabrai bought 2,237,000 shares in the quarter that ended on 06/30/2012, which is 18.3% of the $241 million portfolio of Pabrai Mohnish. Richard Pzena bought 13,475 shares in the quarter that ended on 06/30/2012, which is 0.0031% of the $8.56 billion portfolio of Pzena Investment Management LLC. Ken Heebner sold out his holdings in the quarter that ended on 03/31/2012.
Director Thomas M Schoewe bought 3,800 shares of GM stock on 03/05/2012 at the average price of 26.05. Thomas M Schoewe owns at least 3,800 shares after this. The price of the stock has decreased by 21.15% since. Other insiders have also decreased their positions in the company.
EnPro Industries, Inc. (NPO, Financial): President and CEO Stephen E. Macadam Bought 13,900 Shares
President and CEO of EnPro Industries, Inc. (NPO) Stephen E. Macadam bought 13,900 shares on 08/07/2012 at an average price of $34.04. EnPro Industries, Inc. is a leader in sealing products, metal polymer bearings, compressor systems and other engineered products for use in critical applications by industries worldwide. Enpro Industries, Inc. has a market cap of $668.6 million; its shares were traded at around $34.04 with a P/E ratio of 11.6 and P/S ratio of 0.6.
EnPro Industries recently reported its second quarter 2012 financial results. Net income in the second quarter of 2012 was $10.2 million, or $0.47 a share, compared to $12.2 million, or $0.56 a share, in the second quarter of 2011.
John Keeley owns 1,142,881 shares as of 03/31/2012, which accounts for 0.95% of the $4.94 billion portfolio of Keeley Fund Management.
VP, GC and Secretary Robert Savage Mclean bought 1,130 shares of NPO stock on 08/08/2012 at the average price of 32.65. Robert Savage Mclean owns at least 7,830 shares after this. The price of the stock has increased by 4.26% since. Other insiders have also increased their positions in the company.
Quest Diagnostics Inc (DGX, Financial): President and CEO Stephen H Rusckowski Bought 5,000 Shares
President and CEO of Quest Diagnostics Inc (DGX) Stephen H Rusckowski bought 5,000 shares on 08/07/2012 at an average price of $59.47. Quest Diagnostics Inc., is the provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. Quest Diagnostics Inc has a market cap of $9.4 billion; its shares were traded at around $59.47 with a P/E ratio of 12.7 and P/S ratio of 1.3. The dividend yield of Quest Diagnostics Inc stocks is 1.2%. Quest Diagnostics Inc had an annual average earnings growth of 11.4% over the past 10 years. GuruFocus rated Quest Diagnostics Inc the business predictability rank of 3.5-star.
Quest Diagnostics recently announced that for the second quarter ended June 30, 2012, adjusted income from continuing operations was $187 million, or $1.17 per diluted share, compared to $179 million, or $1.12 per diluted share, in 2011.
Richard Pzena bought 4,959 shares in the quarter that ended on 06/30/2012, which is 0.0035% of the $8.56 billion portfolio of Pzena Investment Management LLC. Ray Dalio bought 34,998 shares in the quarter that ended on 03/31/2012, which is 0.033% of the $6.73 billion portfolio of Bridgewater Associates. Ray Dalio sold out his holdings in the quarter that ended on 06/30/2012.
SVP & CFO Robert Hagemann sold 46,666 shares of DGX stock on 04/02/2012 at the average price of 62. Robert Hagemann owns at least 156,337 shares after this. The price of the stock has decreased by 4.08% since. Other insiders have also decreased their positions in the company.
Solar Senior Capital Ltd (SUNS, Financial): CEO, President Chn of the Brd Michael S Gross Bought 42,824 Shares
CEO, President Chn of the Brd of Solar Senior Capital Ltd (SUNS) Michael S Gross bought 42,824 shares during the past week at an average price of $17.4. Solar Senior Capital Ltd. operates as a business development company under the Investment Company Act of 1940. Solar Senior Capital Ltd has a market cap of $165.5 million; its shares were traded at around $17.4 with a P/E ratio of 20.7 and P/S ratio of 21. The dividend yield of Solar Senior Capital Ltd stocks is 7.2%.
SUNS recently reported earnings of $3.6 million, or $0.38 per share, and net investment income of $3.4 million, or $0.36 per share, for the quarter ended June 30, 2012. Net asset value (NAV) per share increased to $18.54, from $18.15 at December 31, 2011.
CFO, Secretary and Treasurer Richard Peteka bought 1,487 shares of SUNS stock on 05/31/2012 at the average price of 16.45. Richard Peteka owns at least 6,250 shares after this. The price of the stock has increased by 5.78% since. Other insiders have also decreased their positions in the company.
Pacific Biosciences of California (PACB, Financial): Chairman, CEO & President Michael Hunkapiller Bought 400,000 Shares
Chairman, CEO & President of Pacific Biosciences of California (PACB) Michael Hunkapiller bought 400,000 shares on 08/07/2012 at an average price of $1.81. Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. Pacific Biosciences Of California has a market cap of $94.4 million; its shares were traded at around $1.81 with and P/S ratio of 2.8.
PACB recently reported its second quarter 2012 financial results. Gross profit for the second quarter of 2012 totaled $0.3 million, resulting in a gross margin of 4%, compared to a $0.2 million gross loss for the first quarter of 2012 and a negative margin of 2%. Gross profit for the second quarter of 2011 was $7.9 million representing a gross margin of 74%.
Jean-Marie Eveillard bought 150,000 shares in the quarter that ended on 03/31/2012, which is 0.002% of the $25.09 billion portfolio of First Eagle Investment Management, LLC. Lee Ainslie owns 3,543,333 shares as of 03/31/2012, which accounts for 0.17% of the $6.95 billion portfolio of Maverick Capital. John Griffin owns 870,000 shares as of 03/31/2012, which accounts for 0.049% of the $6.04 billion portfolio of Blue Ridge Capital.
General Motors Company (GM, Financial): Chairman & CEO Daniel F Akerson Bought 25,000 Shares
Chairman & CEO of General Motors Company (GM) Daniel F Akerson bought 25,000 shares on 08/08/2012 at an average price of $20.54. General Motors Company is engaged in the designing, manufacturing and retailing of vehicles globally including passenger cars, crossover vehicles, and light trucks, sport utility vehicles, vans and other vehicles. General Motors Company has a market cap of $31.39 billion; its shares were traded at around $20.54 with a P/E ratio of 6.2 and P/S ratio of 0.2.
GM recently announced second quarter net income attributable to common stockholders of $1.5 billion, or $0.90 per fully diluted share. In the second quarter a year ago, GM’s net income attributable to common stockholders was $2.5 billion, or $1.54 per fully diluted share.
Mohnish Pabrai bought 2,237,000 shares in the quarter that ended on 06/30/2012, which is 18.3% of the $241 million portfolio of Pabrai Mohnish. Richard Pzena bought 13,475 shares in the quarter that ended on 06/30/2012, which is 0.0031% of the $8.56 billion portfolio of Pzena Investment Management LLC. Ken Heebner sold out his holdings in the quarter that ended on 03/31/2012.
Director Thomas M Schoewe bought 3,800 shares of GM stock on 03/05/2012 at the average price of 26.05. Thomas M Schoewe owns at least 3,800 shares after this. The price of the stock has decreased by 21.15% since. Other insiders have also decreased their positions in the company.
EnPro Industries, Inc. (NPO, Financial): President and CEO Stephen E. Macadam Bought 13,900 Shares
President and CEO of EnPro Industries, Inc. (NPO) Stephen E. Macadam bought 13,900 shares on 08/07/2012 at an average price of $34.04. EnPro Industries, Inc. is a leader in sealing products, metal polymer bearings, compressor systems and other engineered products for use in critical applications by industries worldwide. Enpro Industries, Inc. has a market cap of $668.6 million; its shares were traded at around $34.04 with a P/E ratio of 11.6 and P/S ratio of 0.6.
EnPro Industries recently reported its second quarter 2012 financial results. Net income in the second quarter of 2012 was $10.2 million, or $0.47 a share, compared to $12.2 million, or $0.56 a share, in the second quarter of 2011.
John Keeley owns 1,142,881 shares as of 03/31/2012, which accounts for 0.95% of the $4.94 billion portfolio of Keeley Fund Management.
VP, GC and Secretary Robert Savage Mclean bought 1,130 shares of NPO stock on 08/08/2012 at the average price of 32.65. Robert Savage Mclean owns at least 7,830 shares after this. The price of the stock has increased by 4.26% since. Other insiders have also increased their positions in the company.
Quest Diagnostics Inc (DGX, Financial): President and CEO Stephen H Rusckowski Bought 5,000 Shares
President and CEO of Quest Diagnostics Inc (DGX) Stephen H Rusckowski bought 5,000 shares on 08/07/2012 at an average price of $59.47. Quest Diagnostics Inc., is the provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. Quest Diagnostics Inc has a market cap of $9.4 billion; its shares were traded at around $59.47 with a P/E ratio of 12.7 and P/S ratio of 1.3. The dividend yield of Quest Diagnostics Inc stocks is 1.2%. Quest Diagnostics Inc had an annual average earnings growth of 11.4% over the past 10 years. GuruFocus rated Quest Diagnostics Inc the business predictability rank of 3.5-star.
Quest Diagnostics recently announced that for the second quarter ended June 30, 2012, adjusted income from continuing operations was $187 million, or $1.17 per diluted share, compared to $179 million, or $1.12 per diluted share, in 2011.
Richard Pzena bought 4,959 shares in the quarter that ended on 06/30/2012, which is 0.0035% of the $8.56 billion portfolio of Pzena Investment Management LLC. Ray Dalio bought 34,998 shares in the quarter that ended on 03/31/2012, which is 0.033% of the $6.73 billion portfolio of Bridgewater Associates. Ray Dalio sold out his holdings in the quarter that ended on 06/30/2012.
SVP & CFO Robert Hagemann sold 46,666 shares of DGX stock on 04/02/2012 at the average price of 62. Robert Hagemann owns at least 156,337 shares after this. The price of the stock has decreased by 4.08% since. Other insiders have also decreased their positions in the company.
